Hospital Virgen de La Luz de Cuenca-ko ikertzaileekin lankidetzan egindako argitalpenak (13)

2021

  1. Mortality of hemodialysis patients is associated with their clinical situation at the start of treatment

    Nefrologia, Vol. 41, Núm. 4, pp. 461-466

2016

  1. Study of glomerulonephritis evolution in Castilla-La Mancha (GLOMANCHA) between 1994 and 2008

    Nefrologia, Vol. 36, Núm. 3, pp. 237-242

2004

  1. Perceived health-related quality of life and comorbidity in diabetic patients starting dialysis (CALVIDIA study)

    Journal of Nephrology, Vol. 17, Núm. 4, pp. 544-551

  2. Perceived mental health at the start of dialysis as a predictor of morbidity and mortality in patients with end-stage renal disease (CALVIDIA study)

    Nephrology Dialysis Transplantation, Vol. 19, Núm. 9, pp. 2347-2353

1992

  1. ASPECTOS EPIDEMIOLOGICOS DEL FRACASO RENAL AGUDO EN EL AREA SANITARIA DE CUENCA

    Nefrologia, Vol. 12, Núm. SUPPL. 4, pp. 87-91

  2. Growth hormone response to acute growth hormone releasing hormone administration in uraemic patients on haemodialysis

    Nephrology Dialysis Transplantation, Vol. 7, Núm. 3, pp. 246-250

1991

  1. Acute interstitial nephritis induced by ethambutol [13]

    Nephron

  2. Anticardiolipin antibodies and lupus anticoagulant in end-stage renal disease

    Nephrology Dialysis Transplantation, Vol. 6, Núm. 8, pp. 543-547

  3. HEMOLISIS Y PANCREATITIS AGUDA EN HEMODIALISIS [3]

    Nefrologia

  4. MANEJO DEL SINDROME ANTIFOSFOLIPIDO

    Nefrologia

1990

  1. SINDROME ANTIFOSFOLIPIDO Y TROMBOSIS DE ACCESOS VASCULARES PARA HEMODIALISIS

    Nefrologia, Vol. 10, Núm. 3, pp. 311-313

  2. Treatment of anemia with recombinant human erythropoietin and the bone marrow response in uremic patients undergoing periodic hemodialysis

    Revista clínica española, Vol. 186, Núm. 9, pp. 419-422

1989

  1. Prolactin's response to acute administration of growth hormone releasing hormone in uremic patients

    Revista Clinica Espanola, Vol. 185, Núm. 8, pp. 399-401